Back to Journals » Vascular Health and Risk Management » Volume 16

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

Total article views   HTML views PDF downloads Totals
5,752 Dovepress* 4,904+ 1,287 6,191
PubMed Central* 848 293 1,141
Totals 5,752 1,580 7,332
*Since 7 October 2020

View citations on PubMed Central and Google Scholar